Total Payments
$88,407
2023 Payments
$1,830
Companies
23
Transactions
93
Medicare Patients
743
Medicare Billing
$252,926
Payment Breakdown by Category
Consulting$49,225 (55.7%)
Travel$23,202 (26.2%)
Research$7,399 (8.4%)
Other$6,480 (7.3%)
Food & Beverage$2,074 (2.3%)
Education$26.89 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $49,225 | 20 | 55.7% |
| Travel and Lodging | $23,202 | 24 | 26.2% |
| Unspecified | $7,399 | 4 | 8.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,480 | 3 | 7.3% |
| Food and Beverage | $2,074 | 39 | 2.3% |
| Education | $26.89 | 3 | 0.0% |
Payments by Type
General
$81,008
89 transactions
Research
$7,399
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Chugai Pharmaceutical Co., Ltd. | $20,606 | 3 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $16,808 | 7 | $0 (2022) |
| Covidien LP | $15,260 | 13 | $0 (2018) |
| Merck Sharp & Dohme LLC | $8,912 | 10 | $0 (2023) |
| Roche Diagnostics Corporation | $8,173 | 10 | $0 (2022) |
| Seagen Inc. | $8,073 | 8 | $0 (2022) |
| Becton, Dickinson and Company | $4,108 | 5 | $0 (2018) |
| DySIS Medical, Inc. | $2,538 | 3 | $0 (2020) |
| PFIZER INC. | $1,500 | 1 | $0 (2017) |
| TESARO, Inc. | $831.81 | 9 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,830 | 1 | Merck Sharp & Dohme LLC ($1,830) |
| 2022 | $16,809 | 16 | AstraZeneca Pharmaceuticals LP ($8,563) |
| 2021 | $16,255 | 9 | AstraZeneca Pharmaceuticals LP ($8,220) |
| 2020 | $2,551 | 4 | DySIS Medical, Inc. ($2,538) |
| 2019 | $21,083 | 5 | Chugai Pharmaceutical Co., Ltd. ($20,606) |
| 2018 | $12,477 | 23 | Covidien LP ($7,443) |
| 2017 | $17,401 | 35 | Covidien LP ($7,817) |
All Payment Transactions
93 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/21/2023 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological) | Consulting Fee | Cash or cash equivalent | $1,830.00 | General |
| Category: VACCINE | ||||||
| 12/11/2022 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $3,082.50 | General |
| Category: Oncology | ||||||
| 11/15/2022 | Roche Diagnostics Corporation | — | Travel and Lodging | Cash or cash equivalent | $79.19 | General |
| Category: None | ||||||
| 11/11/2022 | SECURA BIO, INC. | COPIKTRA (Drug), COPIKTRA, COPIKTRA | Food and Beverage | Cash or cash equivalent | $13.90 | General |
| Category: Hematology and Oncology | ||||||
| 10/20/2022 | Roche Diagnostics Corporation | — | Travel and Lodging | In-kind items and services | $151.72 | General |
| Category: None | ||||||
| 10/18/2022 | Roche Diagnostics Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,980.00 | General |
| Category: None | ||||||
| 10/10/2022 | Roche Diagnostics Corporation | — | Travel and Lodging | In-kind items and services | $210.56 | General |
| Category: None | ||||||
| 10/08/2022 | Roche Diagnostics Corporation | CINtec PLUS Cytology (Device) | Travel and Lodging | In-kind items and services | $334.17 | General |
| Category: Tissue Diagnostics | ||||||
| 09/21/2022 | Roche Diagnostics Corporation | — | Travel and Lodging | In-kind items and services | $739.71 | General |
| Category: None | ||||||
| 09/21/2022 | Roche Diagnostics Corporation | — | Travel and Lodging | In-kind items and services | $597.65 | General |
| Category: None | ||||||
| 09/21/2022 | Roche Diagnostics Corporation | — | Travel and Lodging | In-kind items and services | $40.00 | General |
| Category: None | ||||||
| 09/21/2022 | Roche Diagnostics Corporation | — | Travel and Lodging | In-kind items and services | $40.00 | General |
| Category: None | ||||||
| 09/07/2022 | Roche Diagnostics Corporation | CINtec PLUS Cytology (Device) | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| Category: Tissue Diagnostics | ||||||
| 08/03/2022 | Seagen Inc. | — | Food and Beverage | In-kind items and services | $37.83 | General |
| 06/27/2022 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $3,425.00 | General |
| Category: Oncology | ||||||
| 06/02/2022 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $2,055.00 | General |
| Category: Oncology | ||||||
| 02/15/2022 | EISAI INC. | Lenvima (Drug) | Education | Cash or cash equivalent | $21.76 | General |
| Category: Oncology | ||||||
| 12/22/2021 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $4,110.00 | General |
| Category: Oncology | ||||||
| 07/08/2021 | Seagen Inc. | — | Consulting Fee | Cash or cash equivalent | $7,240.00 | General |
| 06/18/2021 | Seagen Inc. | — | Travel and Lodging | In-kind items and services | $213.18 | General |
| 06/18/2021 | Seagen Inc. | — | Travel and Lodging | In-kind items and services | $208.41 | General |
| 06/18/2021 | Seagen Inc. | — | Travel and Lodging | In-kind items and services | $204.41 | General |
| 06/18/2021 | Seagen Inc. | — | Food and Beverage | In-kind items and services | $114.03 | General |
| 06/18/2021 | Seagen Inc. | — | Food and Beverage | In-kind items and services | $43.44 | General |
| 06/18/2021 | Seagen Inc. | — | Travel and Lodging | In-kind items and services | $12.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 90 | 126 | $39,201 | $10,105 |
| 2022 | 6 | 136 | 282 | $64,233 | $34,685 |
| 2021 | 8 | 276 | 789 | $156,418 | $110,657 |
| 2020 | 7 | 241 | 655 | $184,419 | $97,480 |
Total Patients
743
Total Services
1,852
Medicare Billing
$252,926
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 19 | 47 | $16,403 | $4,375 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 26 | 33 | $8,118 | $2,078 | 25.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 13 | 13 | $6,617 | $1,621 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 21 | 22 | $3,542 | $1,036 | 29.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $4,521 | $995.40 | 22.0% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2022 | 39 | 128 | $20,480 | $20,437 | 99.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 46 | $16,054 | $5,739 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 49 | $12,054 | $4,042 | 33.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $7,126 | $2,196 | 30.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 26 | $5,460 | $1,433 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 19 | $3,059 | $838.29 | 27.4% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2021 | 97 | 539 | $86,240 | $86,240 | 100.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 36 | 73 | $25,477 | $9,418 | 37.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 45 | 65 | $15,990 | $5,849 | 36.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 39 | $6,279 | $2,627 | 41.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 17 | 17 | $8,653 | $2,605 | 30.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $5,343 | $1,588 | 29.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 16 | 25 | $5,250 | $1,388 | 26.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 17 | 18 | $3,186 | $941.80 | 29.6% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2020 | 89 | 453 | $72,480 | $71,946 | 99.3% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2020 | 12 | 12 | $55,140 | $8,345 | 15.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 33 | 62 | $21,638 | $6,793 | 31.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 33 | 33 | $16,797 | $4,887 | 29.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 46 | 67 | $16,482 | $4,597 | 27.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 17 | 17 | $1,354 | $740.73 | 54.7% |
About Dr. Warner Huh, MD
Dr. Warner Huh, MD is a Gynecologic Oncology healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043257173.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Warner Huh, MD has received a total of $88,407 in payments from pharmaceutical and medical device companies, with $1,830 received in 2023. These payments were reported across 93 transactions from 23 companies. The most common payment nature is "Consulting Fee" ($49,225).
As a Medicare-enrolled provider, Huh has provided services to 743 Medicare beneficiaries, totaling 1,852 services with total Medicare billing of $252,926. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecologic Oncology
- Other Specialties Gynecologic Oncology
- Location Birmingham, AL
- Active Since 05/31/2006
- Last Updated 02/01/2024
- Taxonomy Code 207VX0201X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1043257173
Products in Payments
- Avastin (Biological) $20,710
- LYNPARZA (Drug) $16,797
- CINtec PLUS Cytology (Device) $4,334
- BD Onclarity (Device) $4,108
- Ultra 2.0 (Device) $2,538
- GARDASIL 9 (Biological) $1,830
- ZEJULA (Drug) $581.38
- Da Vinci Surgical System (Device) $496.95
- Rubraca (Drug) $455.01
- FOUNDATIONONE (Device) $57.37
- FLOSEAL (Biological) $51.30
- SANCUSO (Drug) $33.58
- Lenvima (Drug) $21.76
- 1588 HD 3 Chip Camera (Device) $21.00
- Neulasta (Biological) $15.64
- VARUBI (Drug) $14.31
- COPIKTRA (Drug) $13.90
- KEYTRUDA (Biological) $13.13
- Endosee (Device) $12.54
- FASLODEX (Drug) $11.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecologic Oncology Doctors in Birmingham
Dr. Rebecca Arend, M.d, M.D
Gynecologic Oncology — Payments: $110,102
Gynecologic Oncology $110,102
Charles Leath
Gynecologic Oncology — Payments: $95,850
Gynecologic Oncology $95,850
David Doo, Md, MD
Gynecologic Oncology — Payments: $17,328
Gynecologic Oncology $17,328
Dr. Wesley Burkett, M.d, M.D
Gynecologic Oncology — Payments: $1,998
Gynecologic Oncology $1,998
Jaclyn Wall, M.d, M.D
Gynecologic Oncology — Payments: $1,486
Gynecologic Oncology $1,486
Margaret Liang
Gynecologic Oncology — Payments: $1,340
Gynecologic Oncology $1,340